Cholesterol Test Market to Reach US$ 18.4 Billion by 2031, Growing at 8% CAGR

A heart attack can happen if the blood flow to any region of the heart is cut off. A tool for determining the risk of cardiovascular disease.

WILMINGTON, DE, UNITED STATES, November 7, 2025 /EINPresswire.com/ -- The global cholesterol test market continues to expand steadily as cardiovascular health awareness rises worldwide. According to a recent industry report, the market was valued at US$ 8,537.52 million in 2021 and is projected to reach US$ 18,441.91 million by 2031, registering a compound annual growth rate (CAGR) of 8% from 2022 to 2031. The market’s upward trajectory is primarily fueled by the increasing incidence of cardiovascular diseases, obesity, diabetes, and lifestyle disorders that necessitate regular cholesterol monitoring.

► Don't Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/request-sample/A15370

A cholesterol test, also known as a lipid profile test, is a diagnostic blood test that measures various lipid components in the blood, including total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. These indicators are essential for assessing heart health, identifying risks of stroke or coronary artery disease, and evaluating the effectiveness of lipid-lowering treatments. The growing global emphasis on preventive healthcare, early diagnosis, and routine health screening has propelled the demand for cholesterol testing kits and analyzers across hospitals, diagnostic laboratories, and home healthcare settings.

The burden of cardiovascular diseases (CVDs) remains one of the leading causes of morbidity and mortality worldwide. According to the World Health Organization (WHO), more than 17 million people die annually due to CVDs, accounting for nearly one-third of global deaths. High blood cholesterol is among the most significant modifiable risk factors contributing to these diseases. As a result, the rise in public health initiatives promoting cholesterol awareness and periodic testing is expected to sustain the growth of the cholesterol test market in the coming years.

The development of innovative testing technologies has significantly transformed the market landscape. Traditional laboratory-based lipid profile tests are now being complemented by portable, point-of-care testing (POCT) devices that provide instant and accurate results. These compact analyzers are particularly beneficial in remote healthcare settings and for patients seeking convenience through home-based testing. Furthermore, advancements in digital health—including mobile-connected cholesterol testing devices and AI-based risk analysis platforms—are enhancing user engagement and diagnostic precision.

Healthcare organizations and governments across the globe are increasing their investments in preventive health programs, with cholesterol screening being an integral component. Many countries are launching public health initiatives that provide free or subsidized cholesterol testing as part of broader wellness campaigns. These efforts not only improve public awareness but also strengthen the global diagnostic infrastructure, thereby expanding the cholesterol testing market.

👉 For Purchase Inquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/A15370

In addition to technological innovation, rising healthcare expenditure and improved access to diagnostic services in emerging economies are propelling the market forward. Rapid urbanization, sedentary lifestyles, and unhealthy dietary habits have resulted in elevated cholesterol levels across populations, further emphasizing the need for routine screening. The growth of private diagnostic chains and corporate wellness programs has also contributed to increased test volumes.

Despite promising growth, the market faces several challenges. The lack of awareness in low- and middle-income countries about the significance of cholesterol testing, coupled with limited access to diagnostic facilities, continues to impede widespread adoption. Moreover, reimbursement issues in certain healthcare systems and variability in test accuracy between traditional and home-use devices may affect consumer confidence. Addressing these barriers through education campaigns and affordable product development will be critical for sustained market expansion.

Regionally, North America dominates the global cholesterol test market, driven by high healthcare awareness, advanced diagnostic infrastructure, and the presence of major market players. The U.S. continues to lead in testing adoption due to its well-established preventive healthcare programs and insurance coverage for lipid profile screening. Europe follows closely, with countries like Germany, the U.K., and France witnessing strong adoption of home-based test kits and digital diagnostic tools. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth over the next decade, fueled by rising cardiovascular disease prevalence, expanding healthcare access, and growing consumer awareness in countries such as India, China, and Japan.

The competitive landscape of the cholesterol test market is characterized by a mix of global diagnostics leaders and regional innovators. Key players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific Inc., Quest Diagnostics, Danaher Corporation, Bio-Rad Laboratories, and Randox Laboratories Ltd. These companies are investing heavily in R&D to develop next-generation diagnostic solutions that combine speed, accuracy, and digital connectivity. Collaborations with digital health platforms and pharmaceutical firms are also helping integrate cholesterol testing into holistic patient care ecosystems.

One of the most notable trends shaping the industry is the integration of AI and machine learning into diagnostic workflows. Predictive analytics and algorithm-based tools can now assess cardiovascular risk levels by analyzing lipid profile data along with other parameters such as blood pressure, BMI, and lifestyle habits. These innovations are enabling more personalized care approaches and improving long-term patient outcomes. Additionally, growing demand for self-testing kits is creating new opportunities for e-commerce channels and pharmacy-based diagnostic offerings, making cholesterol testing more accessible than ever.

Sustainability and ethical manufacturing are also gaining traction in the diagnostic devices sector. Leading manufacturers are increasingly focusing on eco-friendly production processes, reducing plastic waste in testing kits, and improving supply chain efficiency. These initiatives not only align with global environmental goals but also enhance corporate reputation and customer trust.

In summary, the cholesterol test market is set for robust expansion over the next decade, driven by lifestyle changes, rising disease prevalence, and technological evolution. As consumers and healthcare providers alike recognize the value of early detection, demand for convenient, accurate, and digital-enabled cholesterol testing solutions will continue to grow. With innovation, affordability, and accessibility at its core, the market promises a future where proactive health monitoring becomes a global norm rather than an exception.

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ + + + + + +1 800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.